Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Medicenna Therapeutics Corp. (MDNAF) had Cash Flow from Financial Activities of $2.80M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.67M |
|
-- |
|
-- |
|
$3.94M |
|
$-3.94M |
|
$0.27M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.94M |
|
$-3.92M |
|
86.64M |
|
86.64M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$5.87M |
|
-- |
|
$0.09M |
|
$5.96M |
|
$4.69M |
|
-- |
|
$0.06M |
|
$4.75M |
|
$1.21M |
|
$1.18M |
|
$1.21M |
|
92.30M |
|
| Cash Flow Statement Financials | |
$-3.20M |
|
-- |
|
|
Cash Flow from Financial Activities |
$2.80M |
$4.52M |
|
$4.11M |
|
$-0.40M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-303.77% |
|
-312.16% |
|
-61.61% |
|
-303.77% |
|
$0.01 |
|
$-0.04 |
|
$-0.04 |
|